Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel vitronectin receptor antagonists in early development at SB

May 19, 1999

World's smallest transdermal estradiol system launched in U.S.

May 18, 1999

Pharmacologically useful PTPase inhibitors developed by Ontogen and Novo Nordisk

May 18, 1999

New vitronectin receptor ligands for osteoporosis, etc., synthesized by HMR and Genentech

May 18, 1999

Bayer's new CETP inhibitors described in recently published patent

May 17, 1999

New vitronectin receptor ligands emerge from collaborative research at HMR and Genentech

May 17, 1999

Vitronectin receptor antagonists from SB for osteoporosis, cancer, etc.

May 14, 1999

Cholesteryl ester transfer protein inhibitors patented by Bayer

May 14, 1999

Roberts will distribute emergency contraceptive kit in Canada

May 14, 1999

Chromium picolinate identified as insulin assistance factor

May 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...